Literature DB >> 22965481

Intralesional steroid injection for benign vocal fold disorders: a systematic review and meta-analysis.

Chi-Te Wang1, Li-Jen Liao, Po-Wen Cheng, Wu-Chia Lo, Mei-Shu Lai.   

Abstract

OBJECTIVE: Emerging literature had documented the potential usefulness of vocal fold steroid injection (VFSI) as an alternative treatment option for benign vocal lesions. This study aims to conduct a qualitative synthesis and quantitative meta-analysis of vocal fold steroid injection STUDY
DESIGN: Systematic review and meta-analysis.
METHODS: Electronic databases were searched using relevant keywords. Extracted data include author, year of publication, diagnosis, steroid regimen, recurrence and side effects. Reported treatment outcomes were clustered into five categories, i.e. subjective, perceptual, acoustic, aerodynamic, and stroboscopic. Meta-analyses were performed on studies with numerical results using random effects model.
RESULTS: Six articles were identified with a total of 321 patients. All the studies reported significant improvements after VFSI in each category of outcome measurements. Proposed indications for VFSI include vocal nodules, polyp/cyst, Reinke's edema, and scar. Meta-analysis demonstrated a significant increase in maximal phonation time after VFSI by 1.82 seconds (p<0.001, 95% confidence interval (CI): 0.29 ≈ 3.35) and a 27.61 points decrease in voice handicap index (p<0.001, 95% CI: 16.49 ≈ 38.73). Adverse effects include local hematoma, whitish deposition of triamcinolone, and mild vocal fold atrophy, which resolve spontaneously within 1 to 2 months. The recurrence rate after VFSI was between 4% and 31%.
CONCLUSIONS: VFSI is well-tolerated under local anesthesia in the office setting. The invasiveness and morbidity of VFSI are low and the side effects are self-limited. Meta-analyses demonstrated significant improvements from both objective and subjective measurements. Further controlled studies with longer follow-up periods may evaluate the effectiveness of VFSI more reliably.
Copyright © 2012 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965481     DOI: 10.1002/lary.23551

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  Short-term outcome of transcutaneous glucocorticoid injection for laryngeal contact granuloma in females.

Authors:  Ran Zhang; Jinrang Li; Qian Nie; Mukun Wu; Yuanyuan Jia
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-13       Impact factor: 2.503

2.  Long-term Surveillance Following Intralesional Steroid Injection for Benign Vocal Fold Lesions.

Authors:  Chi-Te Wang; Mei-Shu Lai; Po-Wen Cheng
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-06-01       Impact factor: 6.223

3.  Autologous fibroblasts for vocal scars and age-related atrophy: A randomized clinical trial.

Authors:  Yue Ma; Jennifer Long; Milan R Amin; Ryan C Branski; Edward J Damrose; Chih-Kwang Sung; Stratos Achlatis; Ann Kearney; Dinesh K Chhetri
Journal:  Laryngoscope       Date:  2019-12-05       Impact factor: 3.325

4.  Intracordal injection therapy for vocal fold scarring: Steroid versus basic fibroblast growth factor.

Authors:  Miki Nozawa; Satoka Takahashi; Takeharu Kanazawa; Kazuya Kurakami; Tomohiro Hasegawa; Mayu Hirosaki; Manami Kamitomai; Daigo Komazawa; Ujimoto Konomi; Makoto Ito; Yusuke Watanabe
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-22

5.  Unilateral Laryngeal Pacing System and Its Functional Evaluation.

Authors:  Taiping Zeng; Zhiping Zhang; Weiwei Peng; Fei Zhang; Baker Y Shi; Fangyi Chen
Journal:  Neural Plast       Date:  2017-01-19       Impact factor: 3.599

6.  The role of steroid injection for vocal folds lesions in professional voice users.

Authors:  Mohamed Al-Ali; Jennifer Anderson
Journal:  J Otolaryngol Head Neck Surg       Date:  2020-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.